Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Bunting, Melissa M ^a   Shadie, Alexander M ^a   Flesher, Rylie P ^a   Nikiforova, Valentina ^a   Garthwaite, Linda ^a   Tedla, Nicodemus ^a   Herbert, Cristan ^a   Kumar, Rakesh K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; INTERLEUKIN 33; MESSENGER RNA; OVALBUMIN; INTERLEUKIN 33, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNOREACTIVITY; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE; UPREGULATION; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTERLEUKINS; MACROPHAGES, ALVEOLAR; MICE;

EID: 84880897081     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/250938     Document Type: Article

References (50)

1. Dougherty R. H., Fahy J. V., Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clinical and Experimental Allergy 2009 39 2 193 202 2-s2.0-58849162826 10.1111/j.1365-2222.2008.03157.x
2. Simpson A., Tan V. Y. F., Winn J., Svensén M., Bishop C. M., Heckerman D. E., Buchan I., Custovic A., Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. American Journal of Respiratory and Critical Care Medicine 2010 181 11 1200 1206 2-s2.0-77952762424 10.1164/rccm.200907-1101OC
3. Martin R. J., Therapeutic significance of distal airway inflammation in asthma. Journal of Allergy and Clinical Immunology 2002 109 2 S447 S460 2-s2.0-0036174758 (Pubitemid 34155294)
4. Wenzel S. E., Schwartz L. B., Langmack E. L., Halliday J. L., Trudeau J. B., Gibbs R. L., Chu H. W., Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. American Journal of Respiratory and Critical Care Medicine 1999 160 3 1001 1008 2-s2.0-0032875377 (Pubitemid 29442043)
5. In 't Veen J. C. C. M., Smits H. H., Hiemstra P. S., Zwinderman A. E., Sterk P. J., Bel E. H., Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. American Journal of Respiratory and Critical Care Medicine 1999 160 1 93 99 2-s2.0-0032787222 (Pubitemid 29326073)
6. McFadden E. R. Jr., Acute severe asthma. American Journal of Respiratory and Critical Care Medicine 2003 168 7 740 759 2-s2.0-0141504383 10.1164/rccm.200208-902SO (Pubitemid 37188297)
7. Holgate S. T., Exacerbations: the asthma paradox. American Journal of Respiratory and Critical Care Medicine 2005 172 8 941 943 2-s2.0-26944489955 10.1164/rccm.2507007 (Pubitemid 41476529)
8. Green R. M., Custovic A., Sanderson G., Hunter J., Johnston S. L., Woodcock A., Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. British Medical Journal 2002 324, article 763 10.1136/bmj.324.7340.763
9. Murray C. S., Poletti G., Kebadze T., Morris J., Woodcock A., Johnston S. L., Custovic A., Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006 61 5 376 382 2-s2.0-33646555487 10.1136/thx.2005.042523 (Pubitemid 43723318)
10. Bartlett N. W., Walton R. P., Edwards M. R., Aniscenko J., Caramori G., Zhu J., Glanville N., Choy K. J., Jourdan P., Burnet J., Tuthill T. J., Pedrick M. S., Hurle M. J., Plumpton C., Sharp N. A., Bussell J. N., Swallow D. M., Schwarze J., Guy B., Almond J. W., Jeffery P. K., Lloyd C. M., Papi A., Killington R. A., Rowlands D. J., Blair E. D., Clarke N. J., Johnston S. L., Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nature Medicine 2008 14 2 199 204 2-s2.0-38949170602 10.1038/nm1713 (Pubitemid 351214556)
11. Holt P. G., Strickland D. H., Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations. Journal of Allergy and Clinical Immunology 2010 125 5 963 972 2-s2.0-77951665504 10.1016/j.jaci.2010.02.011
12. Borish L., IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics. American Journal of Respiratory and Critical Care Medicine 2010 181 8 769 770 2-s2.0-77953073669 10.1164/rccm.201002-0147ED
13. Siegle J. S., Hansbro N., Herbert C., Yang M., Foster P. S., Kumar R. K., Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. American Journal of Respiratory Cell and Molecular Biology 2006 35 5 565 570 2-s2.0-33750730318 10.1165/rcmb.2006-0135OC (Pubitemid 44706429)
14. Temelkovski J., Hogan S. P., Shepherd D. P., Foster P. S., Kumar R. K., An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998 53 10 849 856 2-s2.0-0031781163 (Pubitemid 28459541)
15. Kumar R. K., Foster P. S., Modeling allergic asthma in mice: pitfalls and opportunities. American Journal of Respiratory Cell and Molecular Biology 2002 27 3 267 272 2-s2.0-0036729230 (Pubitemid 34979284)
16. Nials A. T., Uddin S., Mouse models of allergic asthma: acute and chronic allergen challenge. Disease Models and Mechanisms 2008 1 4-5 213 220 2-s2.0-64249119491 10.1242/dmm.000323
17. + T-lymphocytes in an exacerbation of murine chronic asthma. American Journal of Pathology 2010 177 4 1657 1664 2-s2.0-77957343750 10.2353/ajpath.2010.100019
18. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004 25 12 677 686 2-s2.0-7644231561 10.1016/j.it.2004.09. 015 (Pubitemid 39457982)
19. Edwards J. P., Zhang X., Frauwirth K. A., Mosser D. M., Biochemical and functional characterization of three activated macrophage populations. Journal of Leukocyte Biology 2006 80 6 1298 1307 2-s2.0-33845398215 10.1189/jlb.0406249 (Pubitemid 44904968)
20. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
21. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
22. Liew F. Y., Pitman N. I., McInnes I. B., Disease-associated functions of IL-33: the new kid in the IL-1 family. Nature Reviews Immunology 2010 10 2 103 110 2-s2.0-75549087056 10.1038/nri2692
23. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C. J., Ying S., Pitman N., Mirchandani A., Rana B., Van Rooijen N., Shepherd M., McSharry C., McInnes I. B., Xu D., Liew F. Y., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. Journal of Immunology 2009 183 10 6469 6477 2-s2.0-75549085516 10.4049/jimmunol.0901575
24. Liu X., Li M., Wu Y., Zhou Y., Zeng L., Huang T., Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochemical and Biophysical Research Communications 2009 386 1 181 185 2-s2.0-67649207586 10.1016/j.bbrc.2009.06.008
25. Mizutani N., Nabe T., Yoshino S., IL-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodeling in mice. Immunology 2013 139 2 205 218 10.1111/imm.12071
26. Ohno T., Oboki K., Morita H., Kajiwara N., Arae K., Tanaka S., Ikeda M., Iikura M., Akiyama T., Inoue J.-I., Matsumoto K., Sudo K., Azuma M., Okumura K., Kamradt T., Saito H., Nakae S., Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS ONE 2011 6 4 2-s2.0-79954556380 10.1371/journal.pone.0018404 e18404
27. Kumar R. K., Herbert C., Webb D. C., Li L., Foster P. S., Effects of anticytokine therapy in a mouse model of chronic asthma. American Journal of Respiratory and Critical Care Medicine 2004 170 10 1043 1048 2-s2.0-8444245228 10.1164/rccm.200405-681OC (Pubitemid 39488615)
28. Schneider T., Issekutz A. C., Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. Journal of Immunological Methods 1996 198 1 1 14 2-s2.0-0029861676 10.1016/0022-1759(96)00143-3 (Pubitemid 26348913)
29. Ito K., Herbert C., Siegle J. S., Vuppusetty C., Hansbro N., Thomas P. S., Foster P. S., Barnes P. J., Kumar R. K., Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. American Journal of Respiratory Cell and Molecular Biology 2008 39 5 543 550 2-s2.0-55249088124 10.1165/rcmb.2008-0028OC
30. Herbert C., Hettiaratchi A., Webb D. C., Thomas P. S., Foster P. S., Kumar R. K., Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clinical and Experimental Allergy 2008 38 5 847 856 2-s2.0-42249111884 10.1111/j.1365-2222.2008.02950.x (Pubitemid 351550666)
31. Kumar R. K., Thomas P. S., Seetoo D.-Q., Herbert C., McKenzie A. N. J., Foster P. S., Lloyd A. R., Eotaxin expression by epithelial cells and plasma cells in chronic asthma. Laboratory Investigation 2002 82 4 495 504 2-s2.0-0036229742 (Pubitemid 34311121)
32. Mbawuike I. N., Herscowitz H. B., MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. Journal of Leukocyte Biology 1989 46 2 119 127 2-s2.0-0024320061 (Pubitemid 19188065)
33. Varin A., Gordon S., Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009 214 7 630 641 2-s2.0-68649111832 10.1016/j.imbio.2008.11.009
34. Murray P. J., Wynn T. A., Obstacles and opportunities for understanding macrophage polarization. Journal of Leukocyte Biology 2011 89 4 557 563 2-s2.0-79953678939 10.1189/jlb.0710409
35. Nelson M. P., Christmann B. S., Werner J. L., Metz A. E., Trevor J. L., Lowell C. A., Steele C., IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. Journal of Immunology 2011 186 4 2372 2381 2-s2.0-79951815692 10.4049/jimmunol.1002558
36. Bhatia S., Fei M., Yarlagadda M., Qi Z., Akira S., Saijo S., Iwakura Y., van Rooijen N., Gibson G. A., St. Croix C. M., Ray A., Ray P., Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE 2011 6 1 2-s2.0-79251580630 10.1371/journal.pone.0015943 e15943
37. Mylonas K. J., Nair M. G., Prieto-Lafuente L., Paape D., Allen J. E., Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. Journal of Immunology 2009 182 5 3084 3094 2-s2.0-64849097221 10.4049/jimmunol.0803463
38. Nagarkar D. R., Bowman E. R., Schneider D., Wang Q., Shim J., Zhao Y., Linn M. J., McHenry C. L., Gosangi B., Bentley J. K., Tsai W. C., Sajjan U. S., Lukacs N. W., Hershenson M. B., Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. Journal of Immunology 2010 185 4 2525 2535 2-s2.0-77956909334 10.4049/jimmunol.1000286
39. van Tits L. J. H., Stienstra R., van Lent P. L., Netea M. G., Joosten L. A. B., Stalenhoef A. F. H., Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2. Atherosclerosis 2011 214 2 345 349 2-s2.0-79151484549 10.1016/j.atherosclerosis.2010.11.018
40. Kim E. Y., Battaile J. T., Patel A. C., You Y., Agapov E., Grayson M. H., Benoit L. A., Byers D. E., Alevy Y., Tucker J., Swanson S., Tidwell R., Tyner J. W., Morton J. D., Castro M., Polineni D., Patterson G. A., Schwendener R. A., Allard J. D., Peltz G., Holtzman M. J., Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nature Medicine 2008 14 6 633 640 2-s2.0-44949257271 10.1038/nm1770 (Pubitemid 351809546)
41. Melgert B. N., Oriss T. B., Qi Z., Dixon-McCarthy B., Geerlings M., Hylkema M. N., Ray A., Macrophages: regulators of sex differences in asthma? American Journal of Respiratory Cell and Molecular Biology 2010 42 5 595 603 2-s2.0-77951634926 10.1165/rcmb.2009-0016OC
42. Subrata L. S., Bizzintino J., Mamessier E., Bosco A., McKenna K. L., Wikström M. E., Goldblatt J., Sly P. D., Hales B. J., Thomas W. R., Laing I. A., LeSouëf P. N., Holt P. G., Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. Journal of Immunology 2009 183 4 2793 2800 2-s2.0-70149089062 10.4049/jimmunol.0900695
43. Hume D. A., Macrophages as APC and the dendritic cell myth. Journal of Immunology 2008 181 9 5829 5835 2-s2.0-58749083404
44. Pope S. M., Fulkerson P. C., Blanchard C., Akei H. S., Nikolaidis N. M., Zimmermann N., Molkentin J. D., Rothenberg M. E., Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. Journal of Biological Chemistry 2005 280 14 13952 13961 2-s2.0-17144362809 10.1074/jbc.M406037200 (Pubitemid 40517296)
45. Iwashita H., Morita S., Sagiya Y., Nakanishi A., Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. American Journal of Respiratory Cell and Molecular Biology 2006 35 1 103 109 2-s2.0-33745598586 10.1165/rcmb.2005-0134OC (Pubitemid 43993159)
46. Chen H., Jacobson B. A., Mason L., Wolf S. F., Bowman M. R., FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction. European Respiratory Journal 2010 36 5 1165 1173 2-s2.0-78349242175 10.1183/09031936. 00097609
47. Raes G., Brys L., Dahal B. K., Brandt J., Grooten J., Brombacher F., Vanham G., Noël W., Bogaert P., Boonefaes T., Kindt A., Van Den Bergh R., Leenen P. J. M., De Baetselier P., Ghassabeh G. H., Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. Journal of Leukocyte Biology 2005 77 3 321 327 2-s2.0-20044387192 10.1189/jlb.0304212 (Pubitemid 40289561)
48. Kearley J., Buckland K. F., Mathie S. A., Lloyd C. M., Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. American Journal of Respiratory and Critical Care Medicine 2009 179 9 772 781 2-s2.0-65549152797 10.1164/rccm.200805-666OC
49. Joshi A. D., Oak S. R., Hartigan A. J., Finn W. G., Kunkel S. L., Duffy K. E., Das A., Hogaboam C. M., Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunology 2010 11, article 52 2-s2.0-77957910133 10.1186/1471-2172-11-52
50. Verri W. A. Jr., Souto F. O., Vieira S. M., Almeida S. C. L., Fukada S. Y., Xu D., Alves-Filho J. C., Cunha T. M., Guerrero A. T. G., Mattos-Guimaraes R. B., Oliveira F. R., Teixeira M. M., Silva J. S., McInnes I. B., Ferreira S. H., Louzada P. Jr., Liew F. Y., Cunha F. Q., IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Annals of the Rheumatic Diseases 2010 69 9 1697 1703 2-s2.0-77956024623 10.1136/ard.2009. 122655